172 related articles for article (PubMed ID: 37851339)
1. Systematic analysis of glutamine metabolism family genes and exploration of the biological role of GPT in colorectal cancer.
Dai W; Mo W; Xu W; Han D; Xu X
Aging (Albany NY); 2023 Oct; 15(21):11811-11830. PubMed ID: 37851339
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients.
Shen KY; Chen BY; Gao WC
Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507
[TBL] [Abstract][Full Text] [Related]
3. Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data.
Zhao S; Zhang P; Niu S; Xie J; Liu Y; Liu Y; Zhao N; Cheng C; Lu P
Funct Integr Genomics; 2024 Apr; 24(2):72. PubMed ID: 38594466
[TBL] [Abstract][Full Text] [Related]
4. Identification of glutamine metabolism-related gene signature to predict colorectal cancer prognosis.
Xie Y; Li J; Tao Q; Wu Y; Liu Z; Zeng C; Chen Y
J Cancer; 2024; 15(10):3199-3214. PubMed ID: 38706895
[No Abstract] [Full Text] [Related]
5. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
6. Role of stemness-related genes TIMP1, PGF, and SNAI1 in the prognosis of colorectal cancer through single-cell RNA-seq.
Shen Y; Ni S; Li S; Lv B
Cancer Med; 2023 May; 12(10):11611-11623. PubMed ID: 37017587
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
8. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
Yu S; Chen M; Xu L; Mao E; Sun S
Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
[TBL] [Abstract][Full Text] [Related]
9. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
10. Integrating scRNA-seq and bulk RNA-seq to characterize infiltrating cells in the colorectal cancer tumor microenvironment and construct molecular risk models.
Wang Q; Zhang YF; Li CL; Wang Y; Wu L; Wang XR; Huang T; Liu GL; Chen X; Yu Q; He PF
Aging (Albany NY); 2023 Dec; 15(23):13799-13821. PubMed ID: 38054820
[TBL] [Abstract][Full Text] [Related]
11. ANGPTL2+cancer-associated fibroblasts and SPP1+macrophages are metastasis accelerators of colorectal cancer.
Liu X; Qin J; Nie J; Gao R; Hu S; Sun H; Wang S; Pan Y
Front Immunol; 2023; 14():1185208. PubMed ID: 37691929
[TBL] [Abstract][Full Text] [Related]
12. Single-cell and WGCNA uncover a prognostic model and potential oncogenes in colorectal cancer.
Di Z; Zhou S; Xu G; Ren L; Li C; Ding Z; Huang K; Liang L; Yuan Y
Biol Proced Online; 2022 Sep; 24(1):13. PubMed ID: 36117173
[TBL] [Abstract][Full Text] [Related]
13. Constructing a Tregs-associated signature to predict the prognosis of colorectal cancer patients: A STROBE-compliant retrospective study.
Ping G; Tian Y; Zhou Z
Medicine (Baltimore); 2022 Nov; 101(47):e31382. PubMed ID: 36451426
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation in a novel quantification system of the glutamine metabolism patterns for the prediction of prognosis and therapy response in hepatocellular carcinoma.
Jin S; Cao J; Kong LB
J Gastrointest Oncol; 2022 Oct; 13(5):2505-2521. PubMed ID: 36388696
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
18. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
[TBL] [Abstract][Full Text] [Related]
19. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
20. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.
Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q
BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
